WAFD

Analyst Note: WaFd, Inc. (WAFD)

Date: 2026-06-20 Current Price: $36.48

1. Structural Readiness

• Aggressive/Pre-Breakout Entry: Not recommended for this setup type; the "Forming" state is a partial signal, not a standalone entry trigger.
• Breakout Level: Pending confirmation.
• Current Price: $36.48.
• Extension: Not applicable (price has not broken out).
• ATR Context: Current ATR is 2.1% (Sub-threshold). This indicates lower volatility than the historical "sweet spot" (4–6%), suggesting the setup may be in a consolidation phase rather than an explosive expansion phase.

2. Thesis Layer

• Thesis Classification: Tactical, Setup-Led.
• Macro Thesis: There is no named secular thesis attached to WAFD as of this date. The investment case is not driven by a specific macro narrative (e.g., "rate cut beneficiary" or "regional bank re-rating") but is strictly a function of the structural setup quality and the company's specific operational fundamentals.
• Conviction Weighting: Conviction must be derived entirely from the quality of the "Deep Value Recovery" archetype fit and the strength of the evidence provided in the earnings and filings, rather than external market tailwinds.

3. Business Overview

WaFd, Inc. operates as a bank holding company through its subsidiary, WaFd Bank, a federally-insured Washington state chartered commercial bank.

• Core Business: The company provides lending, depository, insurance, and other banking services to consumers, mid-sized to large businesses, and owners/developers of commercial real estate.
• Geographic Footprint: As of September 30, 2025, the bank operates 208 branches across Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, California, and Texas.
• Strategic Shift: In January 2025, the bank announced it would cease originating consumer single-family home loans and home equity lines of credit (HELOCs) to focus on its core commercial and business lending strengths.
• Loan Portfolio Composition: Recent originations (Q2 2026) were heavily weighted toward Commercial and Industrial (37%), Construction (35%), and Commercial Real Estate (15%). Non-Deposit Financial Institution (NDFI) loans remain negligible at $35 million (17 basis points).
• Balance Sheet Dynamics:
• Deposits: Customer account balances decreased 1.5% to $21.12 billion as of March 31, 2026, though the deposit pipeline increased 66% from December to March ($264M to $439M).
• Funding: Total borrowings increased significantly to $3.06 billion (from $1.76 billion in Sept 2025) to fund securities purchases.
• Asset Mix: Loans receivable decreased by $121.6 million, while investment and mortgage-backed securities increased by $919 million.

4. Archetype and Conviction Analysis

• Archetype: Deep Value Recovery.
• *Fit:* The company is trading at a price point ($36.48) that suggests a recovery play based on improving operational metrics (NIM expansion, strong pipeline) rather than pure growth. The strategic pivot away from consumer loans and the focus on C&I/CRE aligns with a "recovery" of a specialized, higher-yielding franchise.
• Fundamental Spine:
• Margin Expansion: Management expects Net Interest Margin (NIM) to reach 3.0% over the next two years, which they project would drive ROE/ROTCE to 12.5%. Current NIM is 2.81% (Q1 2026), up from 2.55% (Q1 2025).
• Growth Guidance: Management explicitly states an expectation to grow active loan portfolios by 8% to 12% going forward, citing a strong lending pipeline ($1.5B in Q2 originations).
• Credit Quality: Provisions for credit losses increased to $4.0M for the quarter and $7.5M for the six months ended March 31, 2026, compared to $2.75M in the prior year periods. This suggests management is proactively building reserves in a potentially tightening environment, a common trait in value recovery plays.
• Conviction Stack:
• *Thesis Strength:* Moderate. The "Deep Value Recovery" label is supported by the margin inflector narrative (NIM target) and the strategic pivot.
• *Evidence Quality:* High. The evidence block is robust, containing specific Q1 2026 financials and Q2 2026 guidance.
• *Rerating Potential:* Dependent on the successful execution of the 3% NIM target and the ability to fund loan growth without excessive reliance on borrowed funds (borrowings rose 73% YoY).

5. Invalidations, Strengtheners, and Gaps

• Invalidation Triggers:
• A failure to meet the 8-12% loan growth guidance or a significant deterioration in the NDFI/CRE portfolio quality (beyond the current provision increase) would weaken the "Deep Value Recovery" thesis.
• Strengtheners:
• Confirmation of the NIM expansion trajectory toward 3%.
• Successful conversion of the $439M deposit pipeline into low-cost funding.
• Evidence Gaps:
• Valuation Metrics: The provided evidence does not include the current P/E, P/B, or dividend yield as of June 20, 2026. Without these, a precise "Deep Value" valuation check (e.g., is it trading below book?) cannot be fully quantified.
• Asset Quality Ratios: While provisions are disclosed, specific non-performing loan (NPL) ratios or charge-off rates for the current quarter are not explicitly detailed in the provided text, only the provision amounts.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: Management guidance for 8-12% loan growth and strong Q2 originations of $1.5B; NIM expansion from 2.55% to 2.81% with a stated target of 3.0%; strategic pivot away from consumer loans to higher-yield commercial segments. Key risks: Significant increase in borrowings ($3.06B) to fund securities purchases may pressure net income; rising credit provisions ($7.5M for 6 months) indicate potential asset quality headwinds; sub-threshold ATR (2.1%) suggests low volatility and potential lack of immediate momentum. Expected path: Management expects NIM to rise to 3% over the next two years, driving ROE to 12.5%; loan portfolio growth of 8-12% should follow if the pipeline converts. Expected horizon: 6 to 12 months for the structural setup to resolve into a confirmed breakout or invalidation.